166 related articles for article (PubMed ID: 32249633)
1. Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity.
Baccon-Sollier PL; Malki Y; Maye M; Ali LMA; Lichon L; Cuq P; Vincent LA; Masurier N
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):935-949. PubMed ID: 32249633
[TBL] [Abstract][Full Text] [Related]
2. Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells.
Bellet V; Lichon L; Arama DP; Gallud A; Lisowski V; Maillard LT; Garcia M; Martinez J; Masurier N
Eur J Med Chem; 2017 Jan; 125():1225-1234. PubMed ID: 27871038
[TBL] [Abstract][Full Text] [Related]
3. Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity.
Gallud A; Vaillant O; Maillard LT; Arama DP; Dubois J; Maynadier M; Lisowski V; Garcia M; Martinez J; Masurier N
Eur J Med Chem; 2014 Mar; 75():382-90. PubMed ID: 24561668
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.
Sajith AM; Abdul Khader KK; Joshi N; Reddy MN; Syed Ali Padusha M; Nagaswarupa HP; Nibin Joy M; Bodke YD; Karuvalam RP; Banerjee R; Muralidharan A; Rajendra P
Eur J Med Chem; 2015 Jan; 89():21-31. PubMed ID: 25462222
[TBL] [Abstract][Full Text] [Related]
6. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Park JH; El-Gamal MI; Lee YS; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
[TBL] [Abstract][Full Text] [Related]
7. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
[TBL] [Abstract][Full Text] [Related]
8. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.
Lončar B; Perin N; Mioč M; Boček I; Grgić L; Kralj M; Tomić S; Stojković MR; Hranjec M
Eur J Med Chem; 2021 May; 217():113342. PubMed ID: 33751978
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system.
Xie M; Lapidus RG; Sadowska M; Edelman MJ; Hosmane RS
Bioorg Med Chem; 2016 Jun; 24(12):2595-602. PubMed ID: 27134120
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxicity of novel imidazo[4,5-d]azepine compounds derived from marine natural product ceratamine A.
Pan X; Tao L; Ji M; Chen X; Liu Z
Bioorg Med Chem Lett; 2018 Mar; 28(5):866-868. PubMed ID: 29433924
[TBL] [Abstract][Full Text] [Related]
11. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer.
Zhu Q; Wang X; Hu Y; He X; Gong G; Xu Y
Bioorg Med Chem; 2015 Oct; 23(20):6551-9. PubMed ID: 26422786
[TBL] [Abstract][Full Text] [Related]
12. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.
Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E
Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor compounds identification from gossypol Groebke imidazopyridine product.
Wang W; Lu Y; Chen E; Shen K; Li J
Bioorg Chem; 2021 Sep; 114():105146. PubMed ID: 34328859
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
15. Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
Fray MJ; Bull DJ; Cooper K; Parry MJ; Stefaniak MH
J Med Chem; 1995 Sep; 38(18):3524-35. PubMed ID: 7658439
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
17. Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Lima RT; Vasconcelos MH
Eur J Med Chem; 2010 Dec; 45(12):5628-34. PubMed ID: 20926160
[TBL] [Abstract][Full Text] [Related]
18. Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure-activity relationship study.
Meenakshisundaram S; Manickam M; Pillaiyar T
Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900011. PubMed ID: 31596021
[TBL] [Abstract][Full Text] [Related]
19. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-cancer activity of 1,4-disubstituted imidazo[4,5-c]quinolines.
Thigulla Y; Akula M; Trivedi P; Ghosh B; Jha M; Bhattacharya A
Org Biomol Chem; 2016 Jan; 14(3):876-83. PubMed ID: 26592542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]